Sunday, February 5, 2023

Tag: Schizophrenia

“Hidden Valley Road” and Schizophrenia: Do Genes Tell the Story?

25
The “genetics of mental disorders” story told in Kolker's "Hidden Valley Road" involves omission and misrepresentation of genetic research.

The Wisdom of the Symptom Bearer: It’s Always the ‘Crazy’ One...

9
From Medium/Rev. Sheri Heller, LCSW: The 'symptom bearer' or 'identified patient' is the scapegoat who carries the evidence of the familial dysfunction.

Shedding the Limits of “Severe Mental Illness” Labels

58
When people seeking help are relegated to “the Other,” how can they ever form a “therapeutic alliance”? Without collaboration, treatment devolves into coercion and oppression. We must change our language and relationships so new narratives can be born.

An Illness, or Risky Experimentation?

27
Questioning is what I did, but once I started questioning so much of what I had learned and of what my identity had been, it wasn’t obvious to me where I should stop.

Many Service Users Interested in Decreasing Antipsychotic Use with Professional Help

8
New research examines service user attitudes on discontinuing and reducing antipsychotic drugs.

Antipsychotics Linked to Increased Breast Cancer Risk

0
Long-term exposure to prolactin-increasing antipsychotics increases the odds of developing breast cancer.

Antipsychotics Increase Risk of Dementia; New Research Illuminates Why

15
In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.

Psychiatric Drugs may Reduce Social and Emotional Capacities

8
Research finds that social cognition and emotional processing abilities can be disrupted by psychiatric drugs.

Antipsychotic Adherence Research Overlooks Key Information

17
Researchers argue for a shift away from a focus on antipsychotic adherence toward understanding service users’ diverse patterns of use.

Barriers to Shared Decision Making in the Prescription of Antipsychotics

31
Researchers push for a renewed focus on true shared decision-making for patients diagnosed with psychosis.

Minimal Medication Alternatives for Psychosis Needed

4
Researchers question the long-term use of antipsychotics and suggest increased research and investment in psychosocial interventions.

How to Support Healing from Psychosis Versus Imposing Social Control

48
This article is written for the loving supporter or social worker. My hope is that it will help you gain strategies for how to handle the relationship with someone experiencing psychosis.

The BBC, Harrow, and a Public Left in the Dark

77
The recent report by the BBC on medication-free treatment in Norway, when viewed in conjunction with the media silence on Martin Harrow's latest publication, reveals why the public remains misinformed about the long-term effects of antipsychotics.

In Memoriam: Birgitta Alakare

14
On February 19, 2021, the world lost Birgitta Alakare, the former chief psychiatrist at Keropudas Hospital in Tornio, Finland and a pioneer in the development of Open Dialogue.

How Culture Influences Voice Hearing: An Interview with Stanford Anthropologist Tanya...

25
Ayurdhi Dhar interviews Tanya Luhrmann about cultural differences in voice-hearing, diagnosis and damaged identities, and conflicts in psychiatry.

Stepping Into One’s Inner Radiant Space

23
It is hard to step out of the space of diagnoses because of the power it holds. The “doctor” who inflicted on you the awful label of “schizophrenia” or “bipolar” damages you because of the power he holds.

Original Soteria House Members to Speak!

7
Soteria House’s history is complex and fascinating. Soteria Houses have never had the support they needed, but they still managed to change so many lives.

Greater Exposure to Antipsychotics Associated with Worse Long-Term Outcomes

17
A new study finds adverse long-term consequences associated with the increased use of antipsychotics in first-episode psychosis.

The Mirror Repeats: The Art of Phoebe Sparrow Wagner

23
It is uncomfortably difficult to look at Phoebe Sparrow Wagner’s art. That much is intentional. She shakes up the viewer’s sense of wellbeing and security so that they can better identify with the plight of the mental patient.

An FDA Whistleblower’s Documents: Commerce, Corruption, and Death

186
In 2008, a reviewer of psychiatric drugs at the FDA, Ron Kavanagh, complained to Congress that the FDA was approving a new antipsychotic that was ineffective and yet had adverse effects that increased the risk of death. Twelve years later, a review of the whistleblower documents reveal an FDA approval process that can lead to the marketing of drugs sure to harm public health.

Who Is a Danger to Others: The “Mentally Ill” or the...

162
If the cultural and socioeconomic structures of society had, from the beginning, allowed me to function, and even thrive, I undoubtedly never would have felt a need for antidepressants and “therapy.”

Kicking Over a Straw Woman

50
The Galvin family is the quintessential example of "genetic" schizophrenia. But their history of sexual abuse, violence, and trauma provides a clearer and simpler explanation.

Voicehearing, Reinaldo, and My Work as The Writer

5
The Writer has outlined a significant work through my hands, dictated by the voice of someone who lived at some point a long time ago, such as London in 1682 A.D.

Does Stranger Mean Danger?

15
Are those diagnosed with “mental illness” more dangerous than other people? Or have we evolved to sense danger from anything that we believe to be different or "strange"?

Not Stigma, Privacy: Why I Write Under a Pseudonym

37
If I disclose my situation, then professionally, the attributional association of “the therapist with schizophrenia“ will necessarily and inevitably follow. But this is not who I am. Rather, I am a therapist with a private medical issue and I prefer to maintain its confidentiality—no further justification needed.